Ftormetazine

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1P441EE1PH. European Medicines Agency schedules Ftormetazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07822MIG. Ftormetazine generally arises in the molecular formula C21H22F3N3OS. The term FTORMETAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, no. 11 1970, list 10.) FTORMETAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ftormetazine under HS 29343090 and SITC 51578. As of Q4 2014, FTORMETAZINE remains the US FDA Preferred Term for this commodity. Ftormetazine bears US NLM identifiers UMLS ID C1880856 and NCI Concept Code C65774. SMILES: S1c2c(N(C(=O)CCN3CCN(CC3)C)c3c1cccc3)cc(cc2)C(F)(F)F.